ARTICLE AD BOX
![]()
Chennai: Chennai-based Iswarya Fertility Center, a fertility care provider, has announced that it has raised more than Rs 350 crore (approximately $37 million) from global healthcare investment firm OrbiMed Asia.It is one of the largest growth investments in India’s IVF sector, the company claimed in a statement here on Thursday. The investment will be used to establish new centres in existing and underserved markets, strengthen clinical infrastructure, invest in digital capabilities, and expand its embryology talent pipeline.The company currently operates a network of more than 85 centres across eight states.“Our focus over the next phase is to deepen our pan-India presence, enter underserved geographies and keep raising the bar on clinical outcomes. We will invest in our people, technology and patient experience,” managing director Arun Muthuvel said.Veda Corporate Advisors was the financial adviser to the company and its promoters. “The transaction drew strong interest from marquee investors,” said VP Rajan, managing director, Veda Corporate Advisors.



English (US) ·